Ismaeil Haririan | Pharmaceutical Biomaterials | Outstanding Scientist Award

Prof. Ismaeil Haririan | Pharmaceutical Biomaterials | Outstanding Scientist Award

Teharn University of Medical Sciences (TUMS), Iran

Prof. Ismaeil Haririan is a distinguished Professor of Pharmaceutics and Pharmaceutical Biomaterials at the Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), where he also serves as the Founder of the Department of Pharmaceutical Biomaterials and Head of the Biomaterials Research Center. He earned his Pharm.D. from Tabriz University and pursued a Ph.D. in Pharmaceutics at the University of London in 1993, followed by postdoctoral research in targeted drug delivery, which laid the foundation for his lifelong contributions to biomaterials and regenerative medicine. With over three decades of academic and research experience, Prof. Haririan has played a pioneering role in advancing interdisciplinary research that integrates pharmacy, materials science, and biomedical engineering. His research interests span the design of hyaluronic acid hydrogels for bone and cartilage regeneration, 3D pharming and bioprinting, microfluidics in pharmaceutical applications, drug delivery systems, nanomedicine, and pharmaceutical rheology. He has authored more than 120 SCI-indexed articles, earning over 3,600 citations, an h-index of 34, and an i10-index of 65, reflecting the global impact of his work. His research skills extend across tissue engineering, drug delivery system design, nanostructure characterization, and translational medicine, complemented by his strong expertise in mentoring doctoral candidates and industrial trainees. Recognized internationally as a leading figure in pharmaceutical biomaterials, Prof. Haririan has received numerous awards and honors, including recognition as a world leader in bioprinting research between 2022 and 2025. Beyond his scholarly contributions, he has served in editorial capacities, led major research collaborations, and advanced education by supervising Pharm.D. and Ph.D. students. In conclusion, Prof. Haririan embodies academic excellence, visionary leadership, and innovative research, making him one of the most influential scientists in pharmaceutics and biomaterials whose work continues to inspire progress in regenerative medicine and pharmaceutical sciences worldwide.

Profile: Scopus | ORCID

Featured Publications

Al-Jawadri, A. M. H., Karami, Z., Haririan, I., Akrami, M., & Gholami, M. (2025). Development of a bio-inspired phagocytic stable nanoghost with anti-inflammatory properties for management of inflammation in ulcerative colitis. Journal of Drug Targeting, 33(7), 1-15.

Safari, F., Goudarzi, A., Abolghasemi, H., Mohammad, H. A., Akrami, M., Mohammadi, S., & Haririan, I. (2025). Additive manufacturing of regorafenib tablets: Formulation strategies and characterization for colorectal cancer. Polymers, 17(17), 2302.

Sohrabi, R., Miri, A. H., Rad-Malekshahi, M., Saadatpour, F., Pourjabbar, B., Keshel, S. H., Arefian, E., Balalaei, S., Masoumi, A., Khalili, F., Haririan, I., Akrami, M., & Shahriari, M. H. (2025). Corrigendum to “Development of silk fibroin/collagen film containing GI-20 peptide-loaded PLGA nanoparticles against corneal herpes simplex virus-1” [International Journal of Pharmaceutics, 669 (2025), 125022]. International Journal of Pharmaceutics, 674, 125369.

Torabi, M., Haririan, I., Foroumadi, A., Ghanbari, H., & Ghasemi, F. (2024). A deep learning model based on the BERT pre-trained model to predict the antiproliferative activity of anti-cancer chemical compounds. SAR and QSAR in Environmental Research, 35(11), 971-992

Luciano Benedini | Biomaterials | Best Researcher Award

Dr. Luciano Benedini | Biomaterials | Best Researcher Award

Researcher/Professor from INQUISUR-CONICET/UNS, Argentina

Dr. Luciano Alejandro Benedini is an accomplished Argentine researcher specializing in pharmaceutical nanotechnology, biomaterials, and drug delivery systems. Serving as an Adjunct Researcher at INQUISUR-CONICET and Assistant Professor at the Universidad Nacional del Sur (UNS) since 2001, he has significantly contributed to the field of pharmaceutical sciences. Dr. Benedini’s work focuses on the development of nanostructured systems for drug delivery, bone tissue engineering, and the study of colloidal properties of pharmaceutical compounds. His extensive publication record includes over 20 peer-reviewed journal articles and multiple book chapters, reflecting his active engagement in cutting-edge research. Additionally, he has been recognized with several prestigious awards, such as the “INNOVAR 2023” distinction and the Aaron and Fanny Fidelef de Nijamkim’s Award for Best PhD in Chemistry. His dedication to research excellence and innovation makes him a strong candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Benedini’s academic journey began with a degree in Pharmacy from the Universidad Nacional del Sur (UNS), completed between 1997 and 2003. He further pursued his passion for research by obtaining a Ph.D. in Chemistry from the same institution, with his doctoral studies spanning from 2008 to 2012. His thesis, titled “Interaction between a biocompatible surfactant with pharmacological interest structures,” delved into the interactions of biocompatible surfactants with pharmacologically relevant structures, laying the groundwork for his future research endeavors in drug delivery systems and nanotechnology. This robust educational foundation has equipped him with the necessary skills and knowledge to excel in the interdisciplinary field of pharmaceutical sciences.

Professional Experience

Dr. Benedini has amassed over two decades of professional experience in both academic and research settings. Since 2001, he has served as an Assistant Professor in the Department of Biology, Biochemistry, and Pharmacy at UNS, where he has been instrumental in teaching and mentoring students. Concurrently, he holds the position of Adjunct Researcher at INQUISUR-CONICET, a role he has fulfilled since 2015. His professional journey also includes valuable international exposure through postdoctoral fellowships at the University of Santiago de Compostela in Spain and Bielefeld University in Germany. These experiences have enriched his research perspective and facilitated collaborations with leading scientists in his field. Additionally, Dr. Benedini has contributed to the public health sector by practicing as a pharmacist from 2003 to 2008, further demonstrating his commitment to applying scientific knowledge for societal benefit.

Research Interests

Dr. Benedini’s research interests are centered around the development of innovative drug delivery systems, with a particular focus on nanotechnology and biomaterials. He explores the design and characterization of nanostructured carriers, such as liposomes and hydroxyapatite-based composites, for targeted and controlled drug release. His work aims to enhance the efficacy and safety of therapeutic agents, especially in the context of bone tissue engineering and regenerative medicine. Additionally, he investigates the physicochemical properties of pharmaceutical compounds and their interactions with biological membranes, contributing to a deeper understanding of drug behavior at the molecular level. Dr. Benedini’s interdisciplinary approach bridges chemistry, biology, and materials science, positioning him at the forefront of pharmaceutical research.

Research Skills

Dr. Benedini possesses a comprehensive skill set that encompasses various aspects of pharmaceutical research. His expertise includes the synthesis and characterization of nanomaterials, formulation of drug delivery systems, and evaluation of their biological performance. He is proficient in techniques such as spectroscopy, electron microscopy, and rheological analysis, which are essential for assessing the structural and functional properties of biomaterials. Furthermore, his experience in conducting in vitro and in vivo studies enables him to translate laboratory findings into potential clinical applications. Dr. Benedini’s collaborative work with international research groups and his role as a reviewer for esteemed scientific journals underscore his analytical acumen and commitment to maintaining high research standards.

Awards and Honors

Dr. Benedini’s contributions to science have been recognized through numerous awards and honors. Notably, he received the “INNOVAR 2023” distinction from the Ministry of Science and Innovation in the Applied Research category for his project on NanoA. His doctoral research earned him the Aaron and Fanny Fidelef de Nijamkim’s Award for Best PhD in Chemistry in 2012. He has been granted several prestigious fellowships, including postdoctoral positions funded by Fundación Carolina and CONICET, facilitating his research endeavors in Spain and Germany. Additionally, his commitment to societal impact is evident from the First Prize awarded at the 2nd Ibero-American Virtual Congress on Environmental Health in 2024 for his work on raising awareness about drug pollution among school-aged children. These accolades reflect Dr. Benedini’s dedication to advancing scientific knowledge and addressing real-world challenges.

Conclusion

Dr. Luciano Benedini exemplifies the qualities of an outstanding researcher through his extensive academic background, innovative research contributions, and commitment to societal impact. His interdisciplinary approach, combining chemistry, biology, and materials science, has led to significant advancements in drug delivery systems and biomaterials. The recognition he has received from both national and international institutions attests to the relevance and quality of his work. Dr. Benedini’s dedication to mentoring, collaboration, and addressing pressing health issues positions him as a leading figure in pharmaceutical research. His achievements make him a deserving candidate for the Best Researcher Award, reflecting his unwavering commitment to scientific excellence and innovation.

Publications Top Notes

  1. Antibacterial alginate/nano-hydroxyapatite composites for bone tissue engineering: Assessment of their bioactivity, biocompatibility, and antibacterial activity
    L. Benedini, J. Laiuppa, G. Santillán, M. Baldini, P. Messina
    Materials Science and Engineering: C, 115, 111101 (2020) — 82 citations

  2. Adsorption/desorption study of antibiotic and anti-inflammatory drugs onto bioactive hydroxyapatite nano-rods
    L. Benedini, D. Placente, J. Ruso, P. Messina
    Materials Science and Engineering: C, 99, 180–190 (2019) — 56 citations

  3. The ascorbyl palmitate-water system: Phase diagram and state of water
    L. Benedini, E.P. Schulz, P.V. Messina, S.D. Palma, D.A. Allemandi, P.C. Schulz
    Colloids and Surfaces A: Physicochemical and Engineering Aspects, 375 (1–3) (2011) — 50 citations

  4. Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations
    D. Placente, L.A. Benedini, M. Baldini, J.A. Laiuppa, G.E. Santillán, …
    International Journal of Pharmaceutics, 548 (1), 559–570 (2018) — 42 citations

  5. Biomimetic fiber mesh scaffolds based on gelatin and hydroxyapatite nano-rods: Designing intrinsic skills to attain bone reparation abilities
    J. Sartuqui, A.N. Gravina, R. Rial, L.A. Benedini, L.H. Yahia, J.M. Ruso, …
    Colloids and Surfaces B: Biointerfaces, 145, 382–391 (2016) — 39 citations

  6. Self-assembly of 33-mer gliadin peptide oligomers
    M.G. Herrera, L.A. Benedini, C. Lonez, P.L. Schilardi, T. Hellweg, …
    Soft Matter, 11 (44), 8648–8660 (2015) — 36 citations

  7. Colloidal properties of amiodarone in water at low concentration
    L. Benedini, P.V. Messina, R.H. Manzo, D.A. Allemandi, S.D. Palma, E.P. Schulz, …
    Journal of Colloid and Interface Science, 342 (2), 407–414 (2010) — 35 citations

  8. Ascorbyl palmitate interaction with phospholipid monolayers: electrostatic and rheological preponderancy
    M. Mottola, N. Wilke, L. Benedini, R.G. Oliveira, M.L. Fanani
    Biochimica et Biophysica Acta (BBA) – Biomembranes, 1828 (11), 2496–2505 (2013) — 33 citations

  9. Biopolymers for medical applications
    J.M. Ruso, P.V. Messina
    CRC Press (2017) — 31 citations

  10. Surface phase behavior and domain topography of ascorbyl palmitate monolayers
    L. Benedini, M.L. Fanani, B. Maggio, N. Wilke, P. Messina, S. Palma, P. Schulz
    Langmuir, 27 (17), 10914–10919 (2011) — 31 citations

  11. Assessment of synergistic interactions on self-assembled sodium alginate/nano-hydroxyapatite composites: to the conception of new bone tissue dressings
    L. Benedini, D. Placente, O. Pieroni, P. Messina
    Colloid and Polymer Science, 295, 2109–2121 (2017) — 19 citations

  12. Study of the influence of ascorbyl palmitate and amiodarone in the stability of unilamellar liposomes
    L. Benedini, S. Antollini, M.L. Fanani, S. Palma, P. Messina, P. Schulz
    Molecular Membrane Biology, 31 (2–3), 85–94 (2014) — 19 citations

  13. Development of a nonionic azobenzene amphiphile for remote photocontrol of a model biomembrane
    L.A. Benedini, M.A. Sequeira, M.L. Fanani, B. Maggio, V.I. Dodero
    The Journal of Physical Chemistry B, 120 (17), 4053–4063 (2016) — 14 citations

  14. Understanding Recognition and Self-assembly in Biology using the Chemist’s Toolbox. Insight into Medicinal Chemistry
    Z.B. Quirolo, L.A. Benedini, M.A. Sequeira, M.G. Herrera, T.V. Veuthey, …
    Current Topics in Medicinal Chemistry, 14 (6), 730–739 (2014) — 11 citations

  15. Phase behavior of ascorbyl palmitate coagels loaded with oligonucleotides as a new carrier for vaccine adjuvants
    G.V. Ullio Gamboa, L.A. Benedini, P.C. Schulz, D.A. Allemandi
    Journal of Surfactants and Detergents, 19, 747–757 (2016) — 10 citations